Latest filing published 09 Jul 2026 for PTC Therapeutics, INC., €195k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Almstead Neil Gregory: trading record in brief
Almstead Neil Gregory appears in our data through filings on PTC Therapeutics, Inc. shares, published by SEC (Form 4). In total, 7 filings cover trades dated from 22 June 2026 to 9 July 2026.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 9 July 2026, the filings show a transaction worth €195k in PTC Therapeutics, Inc. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Almstead Neil Gregory
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,464 shares@ US$90.24680.0030% mcap1.1% of flowCommonSEC144:0001959173-26-005179
- 24,613 shares@ US$88.88370.029% mcap11.3% of flowCommonSEC144:0001959173-26-005150
- 22,161 shares@ US$85.99780.026% mcap9.8% of flowCommonSEC144:0001959173-26-005117
- 8,130 shares@ US$85.25780.0094% mcap3.4% of flowCommonSEC144:0001959173-26-004919
- 20,960 shares@ US$85.9671CommonSEC144:0001959173-26-004899
- 5,323 shares@ US$85.0257CommonSEC144:0001959173-26-004862
- 23,749 shares@ US$80.9058CommonSEC144:0001959173-26-004813
7 of 7 declarations
